Autolus Therapeutics (AUTL) Shares Outstanding (2021 - 2025)

Autolus Therapeutics (AUTL) has 4 years of Shares Outstanding data on file, last reported at $34425.0 in Q2 2025.

• For the quarter ending Q2 2025, Shares Outstanding fell 99.99% year-over-year to $34425.0; the trailing twelve-month figure through Jun 2025 stood at $34425.0 (down 99.99% YoY), and the FY2024 full-year result was $88.9 million, up 258123.81% from the prior year.
• Shares Outstanding for Q2 2025 stood at $34425.0, roughly flat from $34425.0 in the prior quarter.
• Across five years, Shares Outstanding topped out at $173.1 billion in Q1 2023 and bottomed at $34425.0 in Q4 2023.
• The 5-year median for Shares Outstanding is $91.1 million (2022), against an average of $17.7 billion.
• The widest annual swing landed in 2023, when Shares Outstanding slumped 100.0%; it then soared 26604546700.0% in 2024.
• A 4-year view of Shares Outstanding shows it stood at $34425.0 in 2022, then jumped by 505641.06% to $174.1 million in 2023, then slumped by 48.94% to $88.9 million in 2024, then tumbled by 99.96% to $34425.0 in 2025.
• The last three Shares Outstanding figures came in at $34425.0 (Q2 2025), $34425.0 (Q1 2025), and $88.9 million (Q4 2024), per Business Quant data.

Peer Comparison